CDK5 Inhibitor Seliciclib Promotes Osteoblastic Differentiation of MSCs and Suppresses the Migration of MG-63 Osteosarcoma Cells
Hong En Fu, Haoyu Zhao, Yali Yang, Ke Duan, Tailin Guo
This study shows that Seliciclib promotes osteoblastic differentiation by enhancing F-actin and suppresses osteosarcoma cell migration.
bioRxiv · Dec 7, 2020 · PreprintDevelopmental Biology